Latrophilin-2 Deletion in Cardiomyocyte Disrupts Cell Junction, Leading to D-CMP
Minjun Kang,Choon-Soo Lee,HyunJu Son,Jeongha Lee,Jaewon Lee,Hyun Ju Seo,Moo-Kang Kim,Murim Choi,Hyun-Jai Cho,Hyo-Soo Kim
DOI: https://doi.org/10.1161/circresaha.124.324670
IF: 23.213
2024-10-20
Circulation Research
Abstract:Circulation Research, Ahead of Print. BACKGROUND:Latrophilin-2 (Lphn2), an adhesive GPCR (G protein-coupled receptor), was found to be a specific marker of cardiac progenitors during the differentiation of pluripotent stem cells into cardiomyocytes or during embryonic heart development in our previous studies. Its role in adult heart physiology, however, remains unclear.METHODS:The embryonic lethality resulting fromLphn2deletion necessitates the establishment of cardiomyocyte-specific, tamoxifen-inducibleLphn2knockout mice, which was achieved by crossingLphn2flox/floxmice with mice having MerCreMer (tamoxifen-inducible Cre recombinase) under the α-myosin heavy chain promoter.RESULTS:Tamoxifen treatment for several days completely suppressed Lphn2 expression, specifically in the myocardium, and induced the dilated cardiomyopathy (D-CMP) phenotype with serious arrhythmia and sudden death in a short period of time. Transmission electron microscopy showed mitochondrial abnormalities, blurred Z-discs, and dehiscent myofibrils. The D-CMP phenotype, or heart failure, worsened during myocardial infarction. In a mechanistic study of D-CMP,Lphn2knockout suppressed PGC-1α and mitochondrial dysfunction, leading to the accumulation of reactive oxygen species and the global suppression of junctional molecules, such as N-cadherin (adherens junction), DSC-2 (desmocollin-2; desmosome), and connexin-43 (gap junction), leading to the dehiscence of cardiac myofibers and serious arrhythmia. In an experimental therapeutic trial, activators of p38-MAPK, which is a downstream signaling molecule of Lphn2, remarkably rescued the D-CMP phenotype ofLphn2knockout in the heart by restoring PGC-1α and mitochondrial function and recovering global junctional proteins.CONCLUSIONS:Lphn2 is a critical regulator of heart integrity by controlling mitochondrial functions and cell-to-cell junctions in cardiomyocytes. Its deficiency leads to D-CMP, which can be rescued by activators of the p38-MAPK pathway.
cardiac & cardiovascular systems,peripheral vascular disease,hematology